Evidence map›Paper›PMID 29691457›Full record

ArticleScientific reports2018

Metabolic and Cardiac Adaptation to Chronic Pharmacologic Blockade of Facilitative Glucose Transport in Murine Dilated Cardiomyopathy and Myocardial Ischemia.

Monique R Heitmeier, Maria A Payne, Carla Weinheimer, Attila Kovacs, Richard C Hresko, Patrick Y Jay, Paul W Hruz

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Unraveling the Roles of HIF-1, HO-1, GLUT-1 and GLUT-4 in Myocardial Protection.International journal of drug discovery and pharmacology · 2024
    Article
  2. Article
  3. Review
  4. Article
  5. Metformin Attenuates Cardiac HypertrophyFrontiers in pharmacology · 2022
    Article
  6. Article
  7. Glucose transporters in cardiovascular system in health and disease.Pflugers Archiv : European journal of physiology · 2020
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Monique R HeitmeierDepartment of Pediatrics, Washington University School of Medicine, St. Louis, USA.
Maria A PayneDepartment of Pediatrics, Washington University School of Medicine, St. Louis, USA.
Carla WeinheimerDepartment of Internal Medicine, Washington University School of Medicine, St. Louis, USA.
Attila KovacsDepartment of Internal Medicine, Washington University School of Medicine, St. Louis, USA.
Richard C HreskoDepartment of Pediatrics, Washington University School of Medicine, St. Louis, USA.
Patrick Y JayDepartment of Pediatrics, Washington University School of Medicine, St. Louis, USA.
Paul W HruzDepartment of Pediatrics, Washington University School of Medicine, St. Louis, USA. hruz_p@kids.wustl.edu.
Washington University in St. Louis · US

Funding

Washington University Nutrition Obesity Research CenterP30DK056341 · NIDDK · WASHINGTON UNIVERSITY · PI Brian N Finck · 1999 to 2026
$30.2M
NIDDK NIH HHS P30 DK056341
6 · The paper itself

Abstract

GLUT transgenic and knockout mice have provided valuable insight into the role of facilitative glucose transporters (GLUTs) in cardiovascular and metabolic disease, but compensatory physiological changes can hinder interpretation of these models. To determine whether adaptations occur in response to GLUT inhibition in the failing adult heart, we chronically treated TG9 mice, a transgenic model of dilated cardiomyopathy and heart failure, with the GLUT inhibitor ritonavir. Glucose tolerance was significantly improved with chronic treatment and correlated with decreased adipose tissue retinol binding protein 4 (RBP4) and resistin. A modest improvement in lifespan was associated with decreased cardiomyocyte brain natriuretic peptide (BNP) expression, a marker of heart failure severity. GLUT1 and -12 protein expression was significantly increased in left ventricular (LV) myocardium in ritonavir-treated animals. Supporting a switch from fatty acid to glucose utilization in these tissues, fatty acid transporter CD36 and fatty acid transcriptional regulator peroxisome proliferator-activated receptor α (PPARα) mRNA were also decreased in LV and soleus muscle. Chronic ritonavir also increased cardiac output and dV/dt-d in C57Bl/6 mice following ischemia-reperfusion injury. Taken together, these data demonstrate compensatory metabolic adaptation in response to chronic GLUT blockade as a means to evade deleterious changes in the failing heart.

Indexed as

AnimalsBlood GlucoseCardiomyopathy, DilatedCoronary Artery DiseaseDisease Models, AnimalFatty AcidsFatty Acid Transport ProteinsGlucoseGlucose Transport Proteins, FacilitativeHeart FailureHeart VentriclesMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicMyocardial IschemiaBlood GlucoseFatty AcidsFatty Acid Transport ProteinsGlucoseGlucose Transport Proteins, FacilitativePPAR alphaRitonavir

Identifiers

PMID29691457
PMCPMC5915485
OpenAlexW2801687183

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.